iSpecimen, Inc. (ISPC)

NASDAQ: ISPC · IEX Real-Time Price · USD
2.39
+0.09 (3.91%)
At close: Aug 12, 2022 4:00 PM
2.46
+0.07 (2.93%)
After-hours: Aug 12, 2022 6:16 PM EDT
3.91%
Market Cap 21.22M
Revenue (ttm) 10.12M
Net Income (ttm) -8.59M
Shares Out 8.88M
EPS (ttm) -1.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 166,316
Open 2.29
Previous Close 2.30
Day's Range 2.29 - 2.51
52-Week Range 2.07 - 28.98
Beta n/a
Analysts Buy
Price Target 11.30 (+372.8%)
Earnings Date Aug 4, 2022

About ISPC

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access... [Read more...]

Industry Diagnostics & Research
IPO Date Jun 17, 2021
Employees 59
Stock Exchange NASDAQ
Ticker Symbol ISPC
Full Company Profile

Financial Performance

In 2021, iSpecimen's revenue was $11.14 million, an increase of 36.06% compared to the previous year's $8.18 million. Losses were -$8.96 million, 92.6% more than in 2020.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for ISPC stock is "Buy." The 12-month stock price forecast is 11.3, which is an increase of 372.80% from the latest price.

Price Target
$11.3
(372.80% upside)
Analyst Consensus: Buy
Stock Forecasts

News

iSpecimen Reports Second Quarter 2022 Financial and Operating Results

Enhanced iSpecimen Marketplace® Platform with Data Integration Capabilities to Simplify the Ingestion and Maintenance of Biospecimen Inventories for Providers Enhanced iSpecimen Marketplace® Platform wi...

iSpecimen to Report Second Quarter 2022 Results on August 4, 2022

LEXINGTON, Mass., July 21, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medica...

Why iSpecimen Shares Are Gaining Today?

iSpecimen Inc (NASDAQ: ISPC) has added new global biospecimen suppliers to its proprietary Marketplace platform for advancing oncology and cardiovascular disease research. The new suppliers include a ca...

iSpecimen Adds New Global Biospecimen Suppliers to Proprietary Marketplace Platform for Researchers to Leverage

New Suppliers Will Increase Access to Unique Banked Biospecimens for Advancing Oncology and Cardiovascular Disease Research New Suppliers Will Increase Access to Unique Banked Biospecimens for Advancing...

iSpecimen Appoints Evan Cox as Vice President of Product Management

Industry Veteran Brings Nearly Two Decades of Experience in Healthcare Product Management to the Company Industry Veteran Brings Nearly Two Decades of Experience in Healthcare Product Management to the ...

iSpecimen Presents New Research to Optimize Biobanking at International Society for Biological and Environmental Repo...

Company Gave Three Presentations, Including Oral Discussion on How New Technology Can Support the “Just-in-Time” Approach to Biobanking

iSpecimen to Participate in the H.C. Wainwright Global Investment Conference on May 23-26, 2022

LEXINGTON, Mass., May 16, 2022 (GLOBE NEWSWIRE) --   iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medic...

iSpecimen Reports First Quarter 2022 Financial and Operating Results

- Recently Launched Enhanced iSpecimen Marketplace Platform to Help Scientists More Efficiently Search for Biospecimens - - Recently Launched Enhanced iSpecimen Marketplace Platform to Help Scientists M...

iSpecimen to Report First Quarter 2022 Results on May 10, 2022

LEXINGTON, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), a global, online marketplace that connects scientists in need of biospecimens for medical...

iSpecimen Unveils Enhanced iSpecimen Marketplace Platform to Help Scientists More Efficiently Find Desired Biospecime...

Updated Interface Provides Improved Search and Data Integration Capabilities

iSpecimen Adds Acutis Diagnostics to Marketplace Platform to Support Oncology and Infectious Disease Research

The iSpecimen Marketplace Platform Now Provides Custom Sequencing for Cancer and COVID-19 Biofluid and Tissue Samples The iSpecimen Marketplace Platform Now Provides Custom Sequencing for Cancer and COV...

iSpecimen to Participate in Maxim's 2022 Virtual Growth Conference on March 28-30, 2022

LEXINGTON, Mass., March 15, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), a global, proprietary online marketplace connecting scientists with healthcare provider...

iSpecimen's Global Biospecimen Marketplace Surpasses 200 Suppliers

- Proprietary Marketplace Provides Easy Access to Urgently-Needed Tissues, Biofluids and Cells for Lifesaving Medical Research -

iSpecimen Reports Full Year 2021 Financial Results

Record FY 2021 Revenue of $11.1 Million, Surpassing FY 2020 Revenue of $8.2 Million by 36% Record FY 2021 Revenue of $11.1 Million, Surpassing FY 2020 Revenue of $8.2 Million by 36%

iSpecimen to Participate in the Aegis Virtual Conference on February 24, 2022

LEXINGTON, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ: ISPC) (“iSpecimen” or the “Company”), an online marketplace for human biospecimens, today announced that Christopher Ianelli, ...

iSpecimen to Report Fourth Quarter and Full Year 2021 Results on February 17, 2022

LEXINGTON, Mass., Feb. 03, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ: ISPC) (“iSpecimen” or the “Company”), an online marketplace for human biospecimens, today announced that it will report its fi...

Why ISpecimen Shares Are Surging Higher Today

ISpecimen Inc (NASDAQ: ISPC) is trading higher Thursday after the company announced the addition of a reference lab in New York to support commercial and government customers focused on COVID-19 researc...

iSpecimen Expands Support of COVID-19 Research with Availability of Sequenced Specimens to Detect Variants

LEXINGTON, Mass., Jan. 13, 2022 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced the expansion of its supplier ...

ISPC Stock: What Is Going on With Little-Known iSpecimen Today?

ISPC stock received a $20 price target from Craig-Hallum today. This comes after iSpecimen made several developments during 2021.

See why Craig-Hallum Is Bullish On iSpecimen

Craig-Hallum initiated coverage of iSpecimen Inc (NASDAQ:ISPC) with a Buy rating and $20 price target.  "Much the way Amazon has become the go-to platform for buyers and sellers of consumer goods," the ...

iSpecimen to Participate in the H.C. Wainwright BioConnect Conference on January 10-13, 2022

LEXINGTON, Mass., Jan. 4, 2022 /PRNewswire/ --  iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that Christopher Ianelli, MD, ...

5 Short Squeeze Candidates To Watch: Petros Pharmaceuticals, iSpecimen Top The List Again

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge movie. GameStop Corp (NYSE:GME) and AMC Entertainment Holdings (NYSE:AMC) are two high-profile e...

Other symbols: PTPILGVNRELIVLON

iSpecimen Expands Global Biospecimen Supplier Network, Broadening Footprint Around the World

LEXINGTON, Mass., Dec. 16, 2021 /PRNewswire/ -- iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that it has expanded its globa...

5 Short Squeeze Candidates To Watch: Petros Pharma Tops List With 254% Cost To Borrow, One Of Highest Figures On Record

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge move. GameStop Corp (NYSE: GME) and AMC Entertainment Holdings (NYSE: AMC) are two high-profile ...

Other symbols: GTECLGVNPTPIVLON

iSpecimen Expands Supplier Network of Human Biospecimens to Help Advance Research in Neurological Disorders

LEXINGTON, Mass., Dec. 2, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced it has recently expanded its gl...